MX2016007714A - Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes. - Google Patents

Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes.

Info

Publication number
MX2016007714A
MX2016007714A MX2016007714A MX2016007714A MX2016007714A MX 2016007714 A MX2016007714 A MX 2016007714A MX 2016007714 A MX2016007714 A MX 2016007714A MX 2016007714 A MX2016007714 A MX 2016007714A MX 2016007714 A MX2016007714 A MX 2016007714A
Authority
MX
Mexico
Prior art keywords
milk
peptides
cow
induction
oral tolerance
Prior art date
Application number
MX2016007714A
Other languages
English (en)
Other versions
MX374247B (es
Inventor
Panchaud Alexandre
Blanchard Carine
Nutten Sophie
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2016007714A publication Critical patent/MX2016007714A/es
Publication of MX374247B publication Critical patent/MX374247B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a péptidos recién identificados que son capaces de inducir tolerancia a la leche de vaca, especialmente a ß-lactoglobulina. Los péptidos pueden administrarse a los mamíferos, especialmente a bebés jóvenes en riesgo de alergia a las proteínas de la leche de vaca, para inducir tolerancia oral a la leche de vaca; pueden administrase, además, a niños o adultos que son alérgicos a la leche de vaca para dejar que ocurra la "desensibilización" hacia las proteínas alergénicas de la leche, especialmente ß-lactoglobulina. Los péptidos pueden usarse además, para inducir la tolerancia a las proteínas de la leche de cabra y de búfala, especialmente ß-lactoglobulina. Los péptidos son capaces de modular la respuesta inmune de mamíferos a los alérgenos.
MX2016007714A 2013-12-16 2013-12-16 Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes. MX374247B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/076643 WO2015090347A1 (en) 2013-12-16 2013-12-16 Newly identified peptides for use in the induction of oral tolerance in young mammals

Publications (2)

Publication Number Publication Date
MX2016007714A true MX2016007714A (es) 2017-02-28
MX374247B MX374247B (es) 2025-03-05

Family

ID=49841652

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007714A MX374247B (es) 2013-12-16 2013-12-16 Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes.

Country Status (13)

Country Link
US (1) US10092633B2 (es)
EP (1) EP3082842B1 (es)
CN (3) CN117224652A (es)
AU (1) AU2013407963B2 (es)
BR (1) BR112016012701B1 (es)
ES (1) ES2918577T3 (es)
MX (1) MX374247B (es)
MY (1) MY186968A (es)
PH (1) PH12016501114A1 (es)
PT (1) PT3082842T (es)
RU (1) RU2668155C1 (es)
WO (1) WO2015090347A1 (es)
ZA (1) ZA201604931B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
EP3307090B1 (en) * 2015-06-12 2020-06-03 Société des Produits Nestlé S.A. Combination of tolerogenic peptides and tfg-b for use in the induction and maintenance of oral tolerance in young mammals
MX2018005651A (es) * 2015-11-09 2018-08-01 Mjn Us Holdings Llc Composiciones nutritivas que comprenden lactobacillus rhamnosus gg, asi como butirato de la dieta y/o un compuesto para estimular la formacion de butirato endogeno.
CN108314704B (zh) * 2018-01-25 2020-03-17 海普诺凯营养品有限公司 一种羊乳清蛋白免疫调节肽、其制备方法及其应用
WO2019212330A1 (en) 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
WO2019212329A1 (en) 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
US20240285688A1 (en) 2019-11-07 2024-08-29 N.V. Nutricia Extensive whey protein hydrolysate with tolerogenic peptides
CN113311155B (zh) * 2021-04-09 2022-11-29 深圳市计量质量检测研究院（国家高新技术计量站、国家数字电子产品质量监督检验中心） 一种牛乳蛋白和水牛乳蛋白二联检测卡的制备方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
EP0321603A1 (fr) 1987-12-23 1989-06-28 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
US5620348A (en) 1995-05-12 1997-04-15 Timex Corporation Method of manufacturing electroluminescent lamps having surface designs and lamps produced thereby
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
JP3441411B2 (ja) * 1999-10-12 2003-09-02 明治乳業株式会社 コレステロール低減化ペプチド
RU2192884C2 (ru) 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Вакцина для стимуляции противоопухолевого иммунитета
US20040007700A1 (en) 2002-07-01 2004-01-15 Hazel Danny G. Non-snagging protective guide for fish tapes
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US20100056458A1 (en) * 2005-06-30 2010-03-04 Campina Nederland Holding B.V. Peptides Inhibiting Angiotensin-Converting Enzyme
WO2007090894A1 (en) 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
ES2524067T3 (es) * 2009-12-04 2014-12-03 Mjn U.S. Holdings Llc Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2436389A1 (en) * 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
US20140011742A1 (en) * 2010-12-09 2014-01-09 Mcgill University Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy

Also Published As

Publication number Publication date
US20160375114A1 (en) 2016-12-29
MX374247B (es) 2025-03-05
EP3082842B1 (en) 2022-04-13
PH12016501114B1 (en) 2016-07-11
BR112016012701B1 (pt) 2022-11-16
CN117224652A (zh) 2023-12-15
CN105828830A (zh) 2016-08-03
PH12016501114A1 (en) 2016-07-11
US10092633B2 (en) 2018-10-09
BR112016012701A2 (pt) 2017-09-26
ZA201604931B (en) 2020-01-29
EP3082842A1 (en) 2016-10-26
CN117018181A (zh) 2023-11-10
WO2015090347A1 (en) 2015-06-25
ES2918577T3 (es) 2022-07-19
RU2016128923A (ru) 2018-01-23
RU2668155C1 (ru) 2018-09-26
PT3082842T (pt) 2022-06-17
MY186968A (en) 2021-08-26
AU2013407963B2 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
MX374247B (es) Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes.
EP3555627A4 (en) FIBROBLAST ACTIVATION PROTEIN (FAP) TARGETED IMAGING AND THERAPY
PL3889145T3 (pl) 8-cyjano-5-piperydyno-chinoliny jako antagoniści TLR7/8 oraz ich zastosowanie w leczeniu zaburzeń immunologicznych
BR112016023948A2 (pt) proteínas fc multiméricas
EP3510175A4 (en) OPTIMIZATION OF THERAPEUTIC OPTIONS IN PERSONALIZED MEDICINE
UY36021A (es) Proteìnas fc multimèricas
CO6640254A2 (es) Método para preparar anticuerpos con propiedades mejoradas
EP3609512C0 (en) Inhaled respiratory probiotic for lung diseases in infants, children, and adults
HUE059050T2 (hu) Aminosavakat tartalmazó készítmények mitokondriális rendellenességgel összefüggõ betegségek kezelésében történõ alkalmazásra
BR112019005329A2 (pt) composições de oligossacarídeos de leite humano purificadas
EP3003343A4 (en) BIOMIMETIC PEPTIDE AND BIODEGRADABLE OUTPUT PLATFORM FOR THE TREATMENT OF ANGIOGENESIS AND LYMPHANGIOGENESIS DEPENDENT ILLNESSES
AR106624A1 (es) Composiciones nutricionales que contienen butirato dietario y usos de las mismas
CY1120718T1 (el) Αντι-αναρροϊκη συνθεση που διατηρει την κινητικοτητα του εντερου
MX2016007632A (es) Composiciones sinteticas de la leche que comprenden acidos grasos poliinsaturados (pufa) para promover el establecimiento saludable de la funcion congnitiva en los infantes varones y hembras y niños y niñas.
IL253500B (en) Extracts of edible fungi enriched in vitamin d and compositions thereof and their use in the treatment of immune-related disorders
BR112017018929A2 (en) use of a probiotic and beta-lactoglobulin-derived peptide, composition, kit of parts, method for inducing oral tolerance, and / or treatment, prevention or reduction of the risk of allergy in an individual
EP3402510A4 (en) COMPOSITIONS AND FORMULATIONS OF CABAZITAXEL AND HUMANSERUMALBUMIN
IL264407A (en) Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
MX2016007491A (es) Composiciones de leche sintetica que comprenden acido eicosatrienoico n-6 y lipidos polares para infantes menores y mayores de tres meses para el establecimiento saludable de la funcion cognitiva.
EP3787412C0 (en) PRODUCTION AND SEPARATION OF MILK FRACTIONS BY DIAFILTRATION
CL2016000276A1 (es) Lactoferrina y memoria y velocidad de aprendizaje en niños
CL2018001728A1 (es) Fórmula infantil que comprende péptidos de leche humana
BR112015028890A2 (pt) derivados de piridona para o tratamento de infecções virais e outras doenças
EA201591803A1 (ru) Разовые высокие дозы mva индуцируют защитный иммунный ответ у новорожденных и младенцев

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SOCIETE DES PRODUITS NESTLE S.A.*

FG Grant or registration